nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call for loiasis to be added to the WHO list of neglected tropical diseases
|
Jacobsen, Kathryn H |
|
|
22 |
10 |
p. e299-e302 |
artikel |
2 |
A next generation BCG vaccine moves forward
|
Dockrell, Hazel M |
|
|
22 |
10 |
p. 1404-1406 |
artikel |
3 |
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
|
Jacewicz, Maciej |
|
|
22 |
10 |
p. 1465-1471 |
artikel |
4 |
A severe rash with pancytopenia
|
Narayanan, Shivakumar |
|
|
22 |
10 |
p. 1512 |
artikel |
5 |
Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study
|
Last, Katharina |
|
|
22 |
10 |
p. 1455-1464 |
artikel |
6 |
Balancing access to BPaLM regimens and risk of resistance
|
Van Rie, Annelies |
|
|
22 |
10 |
p. 1411-1412 |
artikel |
7 |
Concerns on the evidence used to challenge established guidelines
|
de Jonge, Stijn |
|
|
22 |
10 |
p. 1415 |
artikel |
8 |
Concerns on the evidence used to challenge established guidelines – Authors' reply
|
Li, Elizabeth |
|
|
22 |
10 |
p. 1415-1416 |
artikel |
9 |
Correction to Lancet Infect Dis 2020; 20: e276–88
|
|
|
|
22 |
10 |
p. e279 |
artikel |
10 |
Disruption to TB services in Ukraine: less than feared
|
Holt, Ed |
|
|
22 |
10 |
p. 1427 |
artikel |
11 |
Dr Hammond's COVID-19 inquiry
|
Ranscombe, Peter |
|
|
22 |
10 |
p. 1433 |
artikel |
12 |
Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial
|
Wu, Dan |
|
|
22 |
10 |
p. 1484-1492 |
artikel |
13 |
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
|
Herman, Gary A |
|
|
22 |
10 |
p. 1444-1454 |
artikel |
14 |
Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera by 2030: opportunities and challenges
|
Deen, Jacqueline |
|
|
22 |
10 |
p. e292-e298 |
artikel |
15 |
Evasion of neutralising antibodies by omicron sublineage BA.2.75
|
Sheward, Daniel J |
|
|
22 |
10 |
p. 1421-1422 |
artikel |
16 |
Global alliance to tackle HIV in children
|
Bagcchi, Sanjeet |
|
|
22 |
10 |
p. 1426 |
artikel |
17 |
Haemophagocytic lymphohistiocytosis associated with bartonella peliosis hepatis following kidney transplantation in a patient with HIV
|
Steed, Danielle |
|
|
22 |
10 |
p. e303-e309 |
artikel |
18 |
Ho Wang Lee
|
Bagcchi, Sanjeet |
|
|
22 |
10 |
p. 1431 |
artikel |
19 |
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals
|
Catho, Gaud |
|
|
22 |
10 |
p. 1493-1502 |
artikel |
20 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
22 |
10 |
p. 1429 |
artikel |
21 |
Is it time to abandon routine antibiotics for transperineal prostate biopsy?
|
Bratt, Ola |
|
|
22 |
10 |
p. 1403-1404 |
artikel |
22 |
Jennifer Furin—campaigning for social justice in tuberculosis
|
Kirby, Tony |
|
|
22 |
10 |
p. 1432 |
artikel |
23 |
Looking back and looking ahead
|
The Lancet Infectious Diseases, |
|
|
22 |
10 |
p. 1399 |
artikel |
24 |
Maintaining genomic surveillance using whole-genome sequencing of SARS-CoV-2 from rapid antigen test devices
|
Martin, Genevieve E |
|
|
22 |
10 |
p. 1417-1418 |
artikel |
25 |
Monkeypox trial to begin in DR Congo
|
Nakkazi, Esther |
|
|
22 |
10 |
p. 1425 |
artikel |
26 |
Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
|
Gruell, Henning |
|
|
22 |
10 |
p. 1422-1423 |
artikel |
27 |
New guidelines for treatment of Ebola virus disease
|
Burki, Talha |
|
|
22 |
10 |
p. 1428-1429 |
artikel |
28 |
Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021–22: a descriptive epidemiological study
|
Charles, Hannah |
|
|
22 |
10 |
p. 1503-1510 |
artikel |
29 |
Plagues and social change: the good, the bad, and the ugly
|
Balakrishnan, Vijay Shankar |
|
|
22 |
10 |
p. 1434 |
artikel |
30 |
Pulmonary Nocardia concava infection in a patient with mantle cell lymphoma receiving bortezomib and rituximab
|
Horino, Taro |
|
|
22 |
10 |
p. 1511 |
artikel |
31 |
Redressing the gender imbalance across the publishing system
|
Pinho-Gomes, Ana-Catarina |
|
|
22 |
10 |
p. 1401-1403 |
artikel |
32 |
Research in brief
|
Devi, Sharmila |
|
|
22 |
10 |
p. 1430 |
artikel |
33 |
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
|
Cotton, Mark F |
|
|
22 |
10 |
p. 1472-1483 |
artikel |
34 |
Sexually transmitted outbreaks and genomic surveillance
|
Chen, Marcus Y |
|
|
22 |
10 |
p. 1409-1411 |
artikel |
35 |
Stewardship of COVID-19 volunteers by nested trial design
|
Gottlieb, Robert L |
|
|
22 |
10 |
p. 1400-1401 |
artikel |
36 |
The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
|
Franco-Paredes, Carlos |
|
|
22 |
10 |
p. 1412-1414 |
artikel |
37 |
Time to evaluate decision support systems for antimicrobial prescribing outside the hospital
|
Delory, Tristan |
|
|
22 |
10 |
p. 1408-1409 |
artikel |
38 |
Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state
|
Faust, Jeremy Samuel |
|
|
22 |
10 |
p. 1419-1420 |
artikel |
39 |
Universal financing and coverage of vaccines
|
Niessen, Louis W |
|
|
22 |
10 |
p. 1406-1407 |
artikel |
40 |
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
|
McMenamin, Martina E |
|
|
22 |
10 |
p. 1435-1443 |
artikel |
41 |
Variation in reported SARS-CoV-2 cases after testing policy changes
|
Halford, Florence |
|
|
22 |
10 |
p. 1418-1419 |
artikel |
42 |
Whipple's disease and Tropheryma whipplei infections: from bench to bedside
|
Boumaza, Asma |
|
|
22 |
10 |
p. e280-e291 |
artikel |
43 |
WHO's antibacterial pipeline reports
|
Balakrishnan, Vijay Shankar |
|
|
22 |
10 |
p. 1424 |
artikel |
44 |
Yes, it matters who is spreading monkeypox
|
Smith, Jonathan |
|
|
22 |
10 |
p. 1416-1417 |
artikel |
45 |
Yes, it matters who is spreading monkeypox – Authors' reply
|
Schneider, Kristan A |
|
|
22 |
10 |
p. 1417 |
artikel |